1,657 Shares in Chemed Co. (NYSE:CHE) Purchased by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Chemed Co. (NYSE:CHE) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 1,657 shares of the company’s stock, valued at approximately $1,064,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in CHE. Rise Advisors LLC purchased a new stake in Chemed in the first quarter worth about $26,000. GAMMA Investing LLC purchased a new stake in shares of Chemed in the 4th quarter worth approximately $37,000. Principal Securities Inc. bought a new position in Chemed during the 4th quarter valued at approximately $51,000. SRS Capital Advisors Inc. raised its stake in Chemed by 110.6% during the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock valued at $58,000 after buying an additional 52 shares during the last quarter. Finally, Mather Group LLC. bought a new stake in Chemed in the first quarter worth $67,000. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the sale, the chief executive officer now directly owns 108,549 shares in the company, valued at approximately $61,605,899.46. The sale was disclosed in a document filed with the SEC, which is available through this link. In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total value of $816,255.00. Following the transaction, the chief executive officer now owns 107,049 shares of the company’s stock, valued at $58,252,854.33. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 4,000 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the sale, the chief executive officer now directly owns 108,549 shares of the company’s stock, valued at approximately $61,605,899.46. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,784 shares of company stock worth $3,240,053. 3.32% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Royal Bank of Canada reduced their price objective on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating for the company in a research note on Tuesday, May 21st.

Chemed Stock Up 0.4 %

Shares of Chemed stock traded up $2.15 on Wednesday, reaching $529.97. The company’s stock had a trading volume of 7,951 shares, compared to its average volume of 81,939. Chemed Co. has a 52 week low of $492.84 and a 52 week high of $654.62. The firm’s fifty day simple moving average is $550.41 and its two-hundred day simple moving average is $586.81. The company has a market capitalization of $8.02 billion, a price-to-earnings ratio of 28.41, a P/E/G ratio of 2.20 and a beta of 0.43.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.41). Chemed had a net margin of 12.36% and a return on equity of 30.52%. The business had revenue of $589.23 million for the quarter, compared to analysts’ expectations of $587.18 million. As a group, research analysts predict that Chemed Co. will post 21.54 EPS for the current year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.30%. Chemed’s dividend payout ratio (DPR) is 8.61%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.